Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eugenie Basseres"'
Autor:
M Jahangir Alam, Khurshida Begum, Md Ekramul Karim, Chenlin Hu, Eugenie Basseres, Chris Lancaster, Kevin W Garey
Publikováno v:
Open Forum Infectious Diseases. 9
Background Ibezapolstat (IBZ) is a non-absorbable antimicrobial currently in phase 2 clinical trials for the treatment of Clostridioides difficile infection (CDI). In vitro and human studies have shown potent activity of IBZ against C. difficile but
Autor:
Bradley T. Endres, Eugenie Basseres, Diane M. Citron, Kerin L. Tyrrell, Khurshida Begum, Chris Lancaster, Yumi A. Warren, M. Jahangir Alam, Kevin W. Garey, Ellie J.C. Goldstein
Publikováno v:
Anaerobe. 79:102682
Three strictly anaerobic strains of Escherichia coli were misidentified as Fusobacterium mortiferum, due to a deletion of the hemB gene which is involved in anaerobic respiration. An unusual antimicrobial susceptibility pattern sparked the further di
Autor:
Klaus Okkenhaug, Olivier Hermine, Ali Alisaac, Sven Kracker, Mailis Maes, Siobhan O. Burns, Anne Durandy, Eugenie Basseres, Adriana S. Albuquerque, Alain Fischer, Davide Eletto, Sarah Inglott, Olivier Papapietro, Anita Chandra, James Curtis, Vincent Plagnol, Capucine Picard, Sergey Nejentsev, Delphine Cuchet-Lourenço
Publikováno v:
Blood, 135(17), 1497-1501. American Society of Hematology
Papapietro, O, Chandra, A, Eletto, D, Inglott, S, Plagnol, V, Curtis, J, Maes, M, Alisaac, A, Albuquerque, A S, Basseres, E, Hermine, O, Picard, C, Fischer, A, Durandy, A, Kracker, S, Burns, S O, Cuchet-Lourenco, D, Okkenhaug, K & Nejentsev, S 2020, ' Topoisomerase 2β mutation impairs early B-cell development ', Blood, vol. 135, no. 17, pp. 1497-1501 . https://doi.org/10.1182/BLOOD.2019003299
Blood
Papapietro, O, Chandra, A, Eletto, D, Inglott, S, Plagnol, V, Curtis, J, Maes, M, Alisaac, A, Albuquerque, A S, Basseres, E, Hermine, O, Picard, C, Fischer, A, Durandy, A, Kracker, S, Burns, S O, Cuchet-Lourenco, D, Okkenhaug, K & Nejentsev, S 2020, ' Topoisomerase 2β mutation impairs early B-cell development ', Blood, vol. 135, no. 17, pp. 1497-1501 . https://doi.org/10.1182/BLOOD.2019003299
Blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c28fe00d133bc8c7e7329747e50ad72
https://research.vumc.nl/en/publications/f941928d-4487-44d9-bcf7-d87fefef40ae
https://research.vumc.nl/en/publications/f941928d-4487-44d9-bcf7-d87fefef40ae
Autor:
M Jahangir, Alam, Seth T, Walk, Bradley T, Endres, Eugenie, Basseres, Mohammed, Khaleduzzaman, Jonathan, Amadio, William L, Musick, Jennifer L, Christensen, Julie, Kuo, Robert L, Atmar, Kevin W, Garey
Publikováno v:
Open Forum Infectious Diseases
Background. Clostridium difficile infection is often considered to result from recent acquisition of a C difficile isolate in a healthcare setting. However, C difficile spores can persist for long periods of time, suggesting a potentially large commu
Autor:
Ximena Cortes-Bratti, Eugénie Bassères, Fabiola Herrera-Rodriguez, Silvia Botero-Kleiven, Giuseppe Coppotelli, Jens B Andersen, Maria G Masucci, Arne Holmgren, Esteban Chaves-Olarte, Teresa Frisan, Javier Avila-Cariño
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e16960 (2011)
BackgroundThioredoxin 80 (Trx80) is an 80 amino acid natural cleavage product of Trx, produced primarily by monocytes. Trx80 induces differentiation of human monocytes into a novel cell type, named Trx80-activated-monocytes (TAMs).Principal findingsI
Externí odkaz:
https://doaj.org/article/a3a2c7311ab8442e9881fec7e662edd7